It's also one of those areas Read more: While this is a very different dynamic and obviously affects a much larger population today, I see it as a historical model of how a benefit was carved out
This conversation became personal for me six months ago
Observational Evidence for GLP-1RAs Real-world data in ARDs, particularly rheumatoid arthritis and systemic lupus erythematosus, suggest GLP-1RA use is associated with lower rates of major adverse cardiovascular events and all-cause mortality, mirroring findings in broader populations
Najafi, S., Bahrami, M., Butler, A
With an increased choice of drugs, success will require targeted clinician engagement, D2C marketing and clear differentiation
Gary Peters retirement and former Rep